Ritchie et al., 2012 - Google Patents
Risk and reputation: a science and risk-based approach to brand protectionRitchie et al., 2012
View PDF- Document ID
- 16137377017348817006
- Author
- Ritchie G
- Ciurczak E
- Flank S
- Hoag S
- Polli J
- Publication year
- Publication venue
- Pharm Eng
External Links
Snippet
Economically motivated adulteration threatens the drug supply through counterfeiting, diversion, and tampering. Current approaches tend toward external protection mechanisms. This article shows an approach that incorporates real time monitoring that can be used as a …
- 230000004224 protection 0 title abstract description 19
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3456—Computer-assisted prescription or delivery of medication, e.g. prescription filling or compliance checking
- G06F19/3462—Computer-assisted distribution of medication from dispensers, i.e. making sure that medication is correctly delivered to patients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infra-red light
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/88—Investigating the presence of flaws or contamination
- G01N21/95—Investigating the presence of flaws or contamination characterised by the material or shape of the object to be examined
- G01N21/9508—Capsules; Tablets
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/324—Management of patient independent data, e.g. medical references in digital format
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10790052B2 (en) | Medication assurance system and method | |
EP1671094B1 (en) | Drug authentication | |
Rebiere et al. | Fighting falsified medicines: the analytical approach | |
Said et al. | Near-infrared spectroscopy (NIRS) and chemometric analysis of Malaysian and UK paracetamol tablets: a spectral database study | |
US20080319795A1 (en) | System and methods for detection and identification of chemical substances | |
Al-Jazairi et al. | Brand and generic medications: are they interchangeable? | |
Zhu et al. | Falsified vardenafil tablets available online | |
Lê et al. | Discriminative and quantitative analysis of antineoplastic taxane drugs using a handheld Raman spectrometer | |
DiFeo | Drug product development: a technical review of chemistry, manufacturing, and controls information for the support of pharmaceutical compound licensing activities | |
Lagarce | Centrally prepared cytotoxic drugs: what is the purpose of their quality control? | |
Ritchie et al. | Risk and reputation: a science and risk-based approach to brand protection | |
JP7374425B2 (en) | Drug identification equipment and methods | |
Al-Mustansir et al. | Studies on pharmacovigilance in Bangladesh: safety issues | |
Isaacs et al. | Spectrometric Assessment of Generic and Brand Drug Quality for a Sentinel Screening Network | |
Almeter et al. | Screening for quality with process analytical technology in a health-system pharmacy: A primer | |
Patel et al. | Drug quality in South Africa: perceptions of key players involved in medicines distribution | |
Cáceres-Pérez et al. | The Current Situation of Medicines Quality in Low-and Middle-Income Countries: New Challenges to be Addressed | |
Kurni et al. | Blockchains in the Pharmaceutical Sector | |
Xu et al. | Factors to consider in developing individual pharmaceutical product quality risk profiles useful to government procurement agencies | |
KANNAN et al. | WHO Global Benchmarking Tool (GBT) For Evaluation Of National Regulatory Systems. | |
Barak et al. | Variability of compounded topical 0.2% nifedipine formulations | |
Secretan et al. | Post hoc study to investigate the potential causes of poor quality of cardiovascular medicines collected in sub-Saharan countries | |
Trippe | Novel Approaches to the Detection of Substandard Medicines | |
HK40010059B (en) | Medication identification system | |
HK40010059A (en) | Medication identification system |